Table 1. Comparison between neuroblastoma patients and controls regarding TP53 gene rs1042522 C>G genotypes frequencies in eastern Chinese children.
Genotype | Cases (N=373) | Controls (N=762) | Pa | Crude OR (95% CI) | P | Adjusted OR (95% CI)b | Pb |
---|---|---|---|---|---|---|---|
rs1042522 C>G (HWE = 0.241) | |||||||
CC | 120 (32.17) | 233 (30.58) | 1.00 | 1.00 | |||
CG | 184 (49.33) | 391 (51.31) | 0.91 (0.69–1.21) | 0.530 | 0.92 (0.70–1.22) | 0.567 | |
GG | 69 (18.50) | 138 (18.11) | 0.97 (0.68–1.40) | 0.873 | 0.99 (0.69–1.42) | 0.947 | |
Additive | 0.782 | 0.98 (0.82–1.17) | 0.782 | 0.98 (0.82–1.18) | 0.855 | ||
Dominant | 253 (67.83) | 529 (69.42) | 0.586 | 0.93 (0.71–1.21) | 0.586 | 0.94 (0.72–1.23) | 0.639 |
Recessive | 304 (81.50) | 624 (81.89) | 0.874 | 1.03 (0.75–1.41) | 0.873 | 1.04 (0.75–1.43) | 0.814 |
Abbreviations: CI, confidence interval, HWE, Hardy–Weinberg equilibrium; OR, odds ratio.
χ2 test for genotype distributions between neuroblastoma patients and controls.
Adjusted for age and gender.